Paula Salazar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paula Salazar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Carola Otth
Molecular Virology Laboratory, Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia 5090000, Chile
2 shared publications - Guillermo Valenzuela-Nieto
Facultad de Ciencias Para el Cuidado de la Salud, Universidad San Sebastián, Valdivia 5090000, Chile
2 shared publications - Hianara Aracelly Bustamante
Molecular Virology Laboratory, Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia 5090000, Chile
2 shared publications - Alejandro Madrid
Laboratorio de Productos Naturales y Síntesis Orgánica (LPNSO), Facultad de Ciencias Naturales y Exactas, Universidad de Playa Ancha, Avda. Leopoldo Carvallo 270, Playa Ancha, Valparaíso 2340000, Chile
1 shared publication - Camila Pino-Belmar
Institute of Biochemistry and Microbiology, Faculty of Sciences, Universidad Austral de Chile, Valdivia 5110566, Chile
1 shared publication - Camila Pino-Belmar
Molecular Virology Laboratory, Institute of Clinical Microbiology, Faculty of Medicine, Universidad Austral de Chile, Valdivia 5090000, Chile
1 shared publication
Latest Publications
- Open Access
- 6 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1440
Bakuchiol: Meroterpenoid Obtained from Psoralea glandulosa L., Positively Impacts on Nrf2-Stability and Activity of Nrf2/HO-1 Signaling Pathway
Psoralea glandulosa L. is a native Chilean plant, traditionally used as an antipyretic, antibacterial, and wound-healing remedy. It exhibits antioxidant, anti-inflammatory, antimicrobial, antitumor, and antipyretic bioactivities, attributed to its high terpenoid and flavonoid contents. Our previous investigations showed that its extracts and resin exert antioxidant activity, with high meroterpenoid Bakuchiol (BAK) content in stems, roots, leaves, and flowers. However, the underlying molecular mechanisms remain unclear. This study aimed to evaluate whether the resinous exudate, dichloromethane (DCM) extract of P. glandulosa L., and BAK activate the Nrf2/HO-1 signaling axis in human keratinocytes. Dose–response assays were conducted in human epidermal keratinocytes (HaCaT). We assessed Nrf2/HO-1 total protein levels, Nrf2 nuclear enrichment, ubiquitination, and CHX-chase by immunoblotting. We evaluated Nrf2 and downstream gene expression and transcriptional activity using RT-qPCR and Dual-Luciferase Reporter assays, respectively. Molecular docking was performed to gain insight into BAK interactions with pathway players. Resinous exudate, DCM extract, and BAK increased total Nrf2 levels. Moreover, BAK promoted Nrf2 nuclear translocation and stabilization, extending its half-life, in correlation with increased ubiquitination. Both DCM extract and BAK upregulated Nrf2 and downstream genes, strongly inducing HO-1 expression, supported by enhanced Nrf2 ARE-mediated transcriptional activity. Docking analysis predicted that BAK interacts with Keap1 at the Kelch domain, contributing to Nrf2 stabilization. These findings support the antioxidant activity of BAK through activation of the Nrf2/HO-1 signaling axis and identify BAK as a promising candidate for further investigation as a potential therapeutic agent for oxidative stress-related disorders.
- 6 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1440
Open AccessBakuchiol: Meroterpenoid Obtained from Psoralea glandulosa L., Positively Impacts on Nrf2-Stability and Activity of Nrf2/HO-1 Signaling Pathway
Psoralea glandulosa L. is a native Chilean plant, traditionally used as an antipyretic, antibacterial, and wound-healing remedy. It exhibits antioxidant, anti-inflammatory, antimicrobial, antitumor, and antipyretic bioactivities, attributed to its high terpenoid and flavonoid contents. Our previous investigations showed that its extracts and resin exert antioxidant activity, with high meroterpenoid Bakuchiol (BAK) content in stems, roots, leaves, and flowers. However, the underlying molecular mechanisms remain unclear. This study aimed to evaluate whether the resinous exudate, dichloromethane (DCM) extract of P. glandulosa L., and BAK activate the Nrf2/HO-1 signaling axis in human keratinocytes. Dose–response assays were conducted in human epidermal keratinocytes (HaCaT). We assessed Nrf2/HO-1 total protein levels, Nrf2 nuclear enrichment, ubiquitination, and CHX-chase by immunoblotting. We evaluated Nrf2 and downstream gene expression and transcriptional activity using RT-qPCR and Dual-Luciferase Reporter assays, respectively. Molecular docking was performed to gain insight into BAK interactions with pathway players. Resinous exudate, DCM extract, and BAK increased total Nrf2 levels. Moreover, BAK promoted Nrf2 nuclear translocation and stabilization, extending its half-life, in correlation with increased ubiquitination. Both DCM extract and BAK upregulated Nrf2 and downstream genes, strongly inducing HO-1 expression, supported by enhanced Nrf2 ARE-mediated transcriptional activity. Docking analysis predicted that BAK interacts with Keap1 at the Kelch domain, contributing to Nrf2 stabilization. These findings support the antioxidant activity of BAK through activation of the Nrf2/HO-1 signaling axis and identify BAK as a promising candidate for further investigation as a potential therapeutic agent for oxidative stress-related disorders.
- Open Access
An Intrinsic Host Defense against HSV-1 Relies on the Activation of Xenophagy with the Active Clearance of Autophagic Receptors
Autophagy engulfs cellular components in double-membrane-bound autophagosomes for clearance and recycling after fusion with lysosomes. Thus, autophagy is a key process for maintaining proteostasis and a powerful cell-intrinsic host defense mechanism, protecting cells against pathogens by targeting them through a specific form of selective autophagy known as xenophagy. In this context, ubiquitination acts as a signal of recognition of the cargoes for autophagic receptors, which direct them towards autophagosomes for subsequent breakdown. Nevertheless, autophagy can carry out a dual role since numerous viruses including members of the Orthoherpesviridae family can either inhibit or exploit autophagy for its own benefit and to replicate within host cells. There is growing evidence that Herpes simplex virus type 1 (HSV-1), a highly prevalent human pathogen that infects epidermal keratinocytes and sensitive neurons, is capable of negatively modulating autophagy. Since the effects of HSV-1 infection on autophagic receptors have been poorly explored, this study aims to understand the consequences of HSV-1 productive infection on the levels of the major autophagic receptors involved in xenophagy, key proteins in the recruitment of intracellular pathogens into autophagosomes. We found that productive HSV-1 infection in human neuroglioma cells and keratinocytes causes a reduction in the total levels of Ub conjugates and decreases protein levels of autophagic receptors, including SQSTM1/p62, OPTN1, NBR1, and NDP52, a phenotype that is also accompanied by reduced levels of LC3-I and LC3-II, which interact directly with autophagic receptors. Mechanistically, we show these phenotypes are the result of xenophagy activation in the early stages of productive HSV-1 infection to limit virus replication, thereby reducing progeny HSV-1 yield. Additionally, we found that the removal of the tegument HSV-1 protein US11, a recognized viral factor that counteracts autophagy in host cells, enhances the clearance of autophagic receptors, with a significant reduction in the progeny HSV-1 yield. Moreover, the removal of US11 increases the ubiquitination of SQSTM1/p62, indicating that US11 slows down the autophagy turnover of autophagy receptors. Overall, our findings suggest that xenophagy is a potent host defense against HSV-1 replication and reveals the role of the autophagic receptors in the delivery of HSV-1 to clearance via xenophagy.
Open AccessAn Intrinsic Host Defense against HSV-1 Relies on the Activation of Xenophagy with the Active Clearance of Autophagic Receptors
Autophagy engulfs cellular components in double-membrane-bound autophagosomes for clearance and recycling after fusion with lysosomes. Thus, autophagy is a key process for maintaining proteostasis and a powerful cell-intrinsic host defense mechanism, protecting cells against pathogens by targeting them through a specific form of selective autophagy known as xenophagy. In this context, ubiquitination acts as a signal of recognition of the cargoes for autophagic receptors, which direct them towards autophagosomes for subsequent breakdown. Nevertheless, autophagy can carry out a dual role since numerous viruses including members of the Orthoherpesviridae family can either inhibit or exploit autophagy for its own benefit and to replicate within host cells. There is growing evidence that Herpes simplex virus type 1 (HSV-1), a highly prevalent human pathogen that infects epidermal keratinocytes and sensitive neurons, is capable of negatively modulating autophagy. Since the effects of HSV-1 infection on autophagic receptors have been poorly explored, this study aims to understand the consequences of HSV-1 productive infection on the levels of the major autophagic receptors involved in xenophagy, key proteins in the recruitment of intracellular pathogens into autophagosomes. We found that productive HSV-1 infection in human neuroglioma cells and keratinocytes causes a reduction in the total levels of Ub conjugates and decreases protein levels of autophagic receptors, including SQSTM1/p62, OPTN1, NBR1, and NDP52, a phenotype that is also accompanied by reduced levels of LC3-I and LC3-II, which interact directly with autophagic receptors. Mechanistically, we show these phenotypes are the result of xenophagy activation in the early stages of productive HSV-1 infection to limit virus replication, thereby reducing progeny HSV-1 yield. Additionally, we found that the removal of the tegument HSV-1 protein US11, a recognized viral factor that counteracts autophagy in host cells, enhances the clearance of autophagic receptors, with a significant reduction in the progeny HSV-1 yield. Moreover, the removal of US11 increases the ubiquitination of SQSTM1/p62, indicating that US11 slows down the autophagy turnover of autophagy receptors. Overall, our findings suggest that xenophagy is a potent host defense against HSV-1 replication and reveals the role of the autophagic receptors in the delivery of HSV-1 to clearance via xenophagy.